Members of the Bcl-2 protein family modulate outer mitochondrial membrane permeability to control apoptosis 1,2 . However, these proteins also localize to the endoplasmic reticulum (ER), the functional significance of which is controversial 3, 4 . Here we provide evidence that anti-apoptotic Bcl-2 proteins regulate the inositol 1,4,5-trisphosphate receptor (InsP 3 R) ER Ca A central feature of molecular models of apoptosis is the control of outer mitochondrial membrane permeability by Bcl-2-related proteins. The pro-apoptotic Bcl-2-related proteins Bax and Bak are required to initiate cytochrome c release from mitochondria in response to diverse apoptotic stimuli 1, 5 . Anti-apoptotic properties of Bcl-2 and Bcl-X L have been attributed to their ability to antagonize Bax/Bak by forming heterodimers that prevent their oligomerization and apoptosis initiation 6 . Pro-and anti-apoptotic Bcl-2 proteins also localize to the ER 3, 7 , and it is now recognized that the ER has an important role in regulating apoptosis 8, 9 . The ER is thought to contribute to apoptosis through its role as the principle Ca 2+ storage organelle in cells [8] [9] [10] [11] . At physiological levels, Ca 2+
A central feature of molecular models of apoptosis is the control of outer mitochondrial membrane permeability by Bcl-2-related proteins. The pro-apoptotic Bcl-2-related proteins Bax and Bak are required to initiate cytochrome c release from mitochondria in response to diverse apoptotic stimuli 1, 5 . Anti-apoptotic properties of Bcl-2 and Bcl-X L have been attributed to their ability to antagonize Bax/Bak by forming heterodimers that prevent their oligomerization and apoptosis initiation 6 . Pro-and anti-apoptotic Bcl-2 proteins also localize to the ER 3, 7 , and it is now recognized that the ER has an important role in regulating apoptosis 8, 9 . The ER is thought to contribute to apoptosis through its role as the principle Ca 2+ storage organelle in cells [8] [9] [10] [11] . At physiological levels, Ca . However, sustained and complete release of ER Ca 2+ can initiate Ca 2+ -dependent forms of apoptosis by activating calpain processing of caspase 12 (ref. 13) or by triggering the opening of the mitochondrial permeability transition pore 14 . It has been suggested that high levels of ER Ca 2+ may sensitize cells to these pathways of apoptosis by providing a higher quantity of released Ca 2+ (ref. 11) . Recent evidence suggests that Bcl-2-related proteins can localize to the ER and the nuclear envelope 3 to regulate permeabilities of these membranes as well as those of mitochondria 7 . However, the effects of this localization have not led to a consistent set of observations that link the functions of these proteins, ER Ca 2+ dynamics and apoptosis control 4 . Genetic studies have suggested that pro-apoptotic Bax and Bak can promote Ca 2+ release from the ER and initiate a caspase 12-associated form of apoptosis 7 , whereas anti-apoptotic Bcl-2 overexpression also promotes Ca 2+ release by causing an unregulated ER Ca 2+ leak 15 . Physiological studies are also conflicting regarding the effects of Bcl-2 proteins on Ca 2+ leakage 4, 11 and InsP 3 R activity 16 . The nature of Bcl-2-associated ER regulation and the effect that this regulation has on apoptosis are therefore uncertain, prompting us to utilize distinct approaches to investigate the ability of the anti-apoptotic Bcl-2 family member Bcl-X L to interact with the InsP 3 ] ER ) and apoptosis. In in vitro pull-down assays, full-length human Bcl-X L interacted with all three mammalian InsP 3 R isoforms (Fig. 1a) . Immunoprecipitation of Bcl-X L coprecipitated type 3 InsP 3 R from COS-7 cell lysates (Fig. 1a) , suggesting that the endogenous proteins interact in vivo. Bcl-2 also binds to InsP 3 R (see Supplementary Information, Fig. S1 ), consistent with previous findings 16 . The interacting region in the InsP 3 R was localized to the C-terminal region of the channel (Fig. 1c) .
The functional consequences of the interaction of Bcl-X L with the InsP 3 R were explored by recording single InsP 3 R channels in native ER membranes, by patch-clamp electrophysiology of outer membranes of isolated nuclei 17 ( Fig. 2a) (Fig. 2b ). Channels were observed in 80% of patches, with the mean number of active channels per patch (N A ) ∼1.8 (Fig. 2c ). When [InsP 3 ] was reduced to 10 nM, channel activity was substantially decreased (P o ∼0.02) (Fig. 2b) , consistent with the [InsP 3 ] dependence of channel gating 17 , and N A was only ∼0.1 (Fig. 2c) . Addition to the pipette solution of purified recombinant human Bcl-X L (rBcl-X L ; 1 µM), with biological activity confirmed in cytochrome c release assays (see Supplementary Information, Fig. S1 ), did not affect the P o or N A of channels activated by 10 µM InsP 3 (data not shown). In contrast, rBcl-X L markedly increased the number of channels (N A ∼1.0) and gating (P o ∼0.6) activated by 10 nM InsP 3 , to levels comparable to those observed with saturating [InsP 3 ] (Fig. 2b, c) . The product of P o and N A , a measure of total InsP 3 R-mediated ion flux across the ER membrane, was increased by over two orders of magnitude in the presence of Bcl-X L (Fig. 2c) .
InsP 3 R channel activity in nuclei isolated from cells transiently transfected with Bcl-X L showed enhanced N A and P o in 10 nM InsP 3 in the absence of added recombinant protein (Fig. 2b, c) , demonstrating an in vivo physical and functional membrane-delimited interaction between the InsP 3 R and Bcl-X L that was sufficiently strong to survive the nuclear isolation protocol. Bcl-X L -enhanced channel activities required InsP 3 binding because they were not observed in the absence of added InsP 3 (Fig. 2b) (Fig. 2d) . Thus, Bcl-X L -activated InsP 3 R channels retained biphasic [Ca 2+ ] i regulation. Taken together, these data indicate that Bcl-X L binding to the C terminus of the InsP 3 R allosterically increases the sensitivity of the channel to very low levels of InsP 3 that may exist in resting or minimally stimulated cells 18 at physiological [Ca 2+ ]. This suggests that the in vivo interaction of InsP 3 R with Bcl-X L does not induce an unregulated Ca 2+ leak but rather increases the dynamic sensitivity of a highly regulated Ca 2+ permeability of the ER membrane. Purified recombinant Bax, a multi-domain family member, and tBid, a BH3-only member, each disrupted binding of InsP 3 R to GST-Bcl-X L (Fig. 3a) and abolished the functional effects of expressed Bcl-X L (Fig. 3b,  c) . In contrast, neither protein affected gating in the absence of Bcl-X L (see Supplementary Information, Fig. S2 ). It has been reported that Bcl-X L and Bax can form ion channels in artificial membrane systems 19, 20 . However, novel conductances were never observed when either Bcl-X L , Bax, or tBid was present in the patch pipette solution, or when Bcl-X L was overexpressed, indicating that under the present experimental conditions these proteins do not form ion channels in native ER membranes.
The cell physiological implications of the Bcl-X L -InsP 3 R interaction were evaluated using chicken DT40 B-cell lines expressing either Bcl-X L or vector alone (Fig. 4a) ) by 25% (Fig. 4b) , consistent with some previous observations 4, 11 . In contrast, stable ( depends critically on expression of the InsP 3 R, consistent with the hypothesis that Bcl-X L -mediated enhanced InsP 3 R ligand sensitivity is the molecular basis of the Bcl-2-enhanced ER Ca 2+ permeability observed previously [22] [23] [24] . Next we examined whether lowered Ca 2+ ER as a consequence of Bcl-X L expression represents a fundamental control point in the regulation of apoptosis, because it reduces the amount of Ca 2+ released through the InsP 3 R by pro-apoptotic signals. DT40 pre-B cells undergo apoptosis following immunoglobulin receptor crosslinking in a process that recapitulates negative selection 25 . Bcl-X L blocks B-cell receptor (BCR)-mediated apoptosis 26 . Therefore, we examined antigen-receptor-mediated apoptosis in DT40-WT and DT40-InsP 3 R-KO cells stably expressing either Bcl-X L or empty vector. An anti-BCR antibody (anti-IgM) elicited comparable [Ca 2+ ] i transients in Bcl-X L -expressing and control wild-type cells (Fig. 4c) , whereas no [Ca 2+ ] i transients were observed in the InsP 3 R-KO cells 21 (data not shown). DT40-InsP 3 R-KO cells were resistant to apoptosis compared with DT40-WT cells during the initial 24 h (Fig. 4d) , consistent with previous observations 21 . However, the resistance was transient, with apoptosis at later times being independent of InsP 3 R expression. Bcl-X L inhibited apoptosis in both wild-type and InsP 3 R-KO cells, as expected, because Bcl-X L has ER-independent (mitochondrial) mechanisms of action. We reasoned that if Bcl-X L was anti-apoptotic because it lowered Ca 2+ ER and therefore reduced the amount of Ca 2+ that could be conveyed from the ER to mitochondria following InsP 3 R activation 9, 11 , then InsP 3 R-KO cells expressing Bcl-X L should have maximal protection against apoptosis because they lack the mechanism (InsP 3 R) to convey Ca 2+ from the ER to mitochondria. Surprisingly, the anti-apoptotic action of Bcl-X L was significantly ] was 1 µM, optimal for channel activity 17 ; arrow indicates zero current level. (c) Summary of the effects of Bcl-X L on InsP 3 R channel activity. In pipettes containing 10 nM InsP 3 , the open probability (P o ) increased from 0.022 ± 0.001 (n = 2) to 0.61 ± 0.09 (n = 10) with addition of 1 µM rBcl-X L (n = number of patches used in P o determination). Similarly, when Bcl-X L was overexpressed, P o increased to 0.42 ± 0.05 (n = 11).
Bcl-X L also increased the number of activated channels (N A ). In 10 nM InsP 3 , N A was increased from 0.10 ± 0.07 (n = 20) under control conditions to 1.00 ± 0.16 (n = 54) and 1.18 ± 0.17 (n = 61) in the presence of recombinant or expressed Bcl-X L , respectively. The total ER ion flux as indicated by the product N A P o was increased by Bcl-X L (note log scale). Asterisks indicate P < 0.001, unpaired t-test. Both His-and Flag-tagged rBcl-X L , generated using distinct purification protocols, were equally effective, whereas His-tagged NCS-1, which does not interact with InsP 3 R (ref. 32) , had no effect either alone or in combination with 10 nM InsP 3 (data not shown). greater in DT40-WT cells compared with InsP 3 R-KO cells (Fig. 4d and see Supplementary Information, Fig. S3c ). These data demonstrate that the presence of InsP 3 R is required for Bcl-X L to be fully efficacious as an anti-apoptotic mediator.
The ER is an important control point for apoptotic responses to diverse stimuli 8, 9 . Our results provide a molecular mechanism that links the ER, Ca 2+ and Bcl-2 family proteins to apoptosis, involving the ubiquitous InsP 3 R ER Ca 2+ release channel as a target of a direct effector function of anti-apoptotic Bcl-X L . This function of Bcl-X L is antagonized by proapoptotic family members, which conforms to a proposed rheostat model in which the balance of pro-to anti-apoptotic Bcl-2 members regulates apoptosis 10 , but differs from the prevailing concept that anti-apoptotic Bcl-2 proteins prevent apoptosis solely by antagonizing pro-apoptotic Bcl-2 family members 2, 6 . Whereas this paradigm may account for the competing effects of pro-and anti-apoptotic members at mitochondria, the present results suggest that the converse is true at the ER. Here, the pro-apoptotic family member Bax can reverse the function of Bcl-X L without affecting ER permeability on its own.
Previous studies that observed reduced Ca 2+ ER in response to Bcl-2 expression or Bax/Bak deficiency concluded that the underlying mechanism is associated with an enhanced ER Ca 2+ leak 15, [22] [23] [24] . The current results establish the molecular identity of the enhanced leak to be the InsP 3 R. It was proposed that phosphorylation status of the type 1 InsP 3 R has not been consistently observed 4, 11 . The current observations demonstrate that this effect of Bcl-X L is InsP 3 Rdependent, with Bcl-X L -stimulated InsP 3 R channel activity remaining exquisitely regulated by its ligands InsP 3 and Ca
2+
. Thus, cell-type differences in basal concentrations of these ligands and InsP 3 R expression can contribute to the magnitude of the effect of Bcl-2 expression on Ca 2+ ER , which might reconcile discrepant published observations.
Previously it was believed that reducing InsP 3 -mediated ER Ca 2+ release would protect against Ca
-induced mitochondrial permeability transition 11, 14 . This model may possibly account for the early transient protection observed in the control InsP 3 R-KO cells (Fig. 4d) , but it is insufficient to account for the InsP 3 R-dependent anti-apoptotic effects of Bcl-X L observed in DT40 cells. If the sole function of Bcl-X L at the ER was to lower [Ca 2+ ] ER , as a mechanism to protect mitochondria from toxic effects of released Ca release channels prevents delivery of Ca 2+ to mitochondria. However, InsP 3 R expression conferred greater Bcl-X L -mediated protection. Thus, despite the correlation between reduced [Ca 2+ ] ER and apoptosis resistance observed here and previously 11 , the InsP 3 R provides an anti-apoptotic signal that cannot be accounted for by reduced mitochondrial Ca 2+ delivery through its effect on [Ca 2+ ] ER . What is the nature of the anti-apoptotic signal that is conferred by InsP 3 R expression? We reasoned that Ca 2+ released from the ER can enhance mitochondrial function by stimulating the citric-acid cycle and oxidative phosphorylation with consequent production of ATP and other important metabolic intermediates 12 . We speculated that maintenance of cellular metabolic homeostasis by Ca 2+ activation of mitochondrial metabolism would enable cells to better withstand apoptotic insults. In such a model, Bcl-X L interaction with the InsP 3 R generates [Ca 2+ ] i signals that enhance cellular bioenergetics that afford apoptosis resistance. In single DT40-WT cells perfused with serum-containing medium, infrequent, spontaneous, transient [Ca 2+ ] i spikes were observed in fewer than 4% of cells (Fig. 5a, b) . In contrast, spontaneous [Ca 2+ ] i spikes were observed in over 25% of Bcl-X L -expressing DT40-WT cells and these spikes were consistently of higher frequency (Fig. 5a, b) . Similarly, [Ca 2+ ] i oscillations triggered in response to a low concentration of antiIgM were observed in more Bcl-X L -expressing wild-type cells than in control wild-type cells (see Supplementary Information, Fig. S4 ), reminiscent of observed Bcl-2 enhancement of ligand-induced [Ca 2+ ] i oscillations 23 . These spikes represent transient release from ER through InsP 3 R because they were absent in DT40-InsP 3 R-KO cells (Fig. 5a) 12, 27 . Bcl-X L elevated NAD(P)H levels in both wild-type and InsP 3 R-KO cells, as observed in other cell types 28 , but the enhancement was greater in the cells expressing InsP 3 R (Fig. 5c, d) . In wild-type cells, the elevated signal was in part due to increased mitochondrial in b) . Similar results were obtained using independent clones (see Supplementary Information, Fig. S3 ).
NADH because the FCCP-induced fluorescence decrease from basal levels -although not different from those observed in InsP 3 R-KO cells -was greater in the Bcl-X L -expressing cells (P < 0.05; n = 7), a result that cannot be accounted for by increased numbers of mitochondria (Fig. 4a) (Fig. 4b ), NAD(P)H fluorescence was unchanged in the Bcl-X L -transfected wildtype cells (Fig. 5c,d) , whereas it was enhanced in the control wild-type cells (Fig. 5c) to levels closer to those achieved in the Bcl-X L -transfected cells (Fig. 5c) , with kinetics correlated with the BCR-induced InsP 3 Rmediated [Ca 2+ ] i signal (Fig. 4b) . These results suggest either that mitochondrial dehydrogenases in the Bcl-X L -transfected wild-type cells were already maximally stimulated under resting conditions, or that Ca 2+ -stimulated NADH production was well compensated by increased oxidation with higher flux through the electron transport chain in these cells. In InsP 3 R-KO cells, anti-IgM elicited neither a [Ca 2+ ] i response (data not shown) nor a stimulation of NAD(P)H fluorescence (Fig. 5c,  d) , demonstrating that the stimulation observed in wild-type cells was mediated by ER Ca 2+ release. Similar results were obtained in different cell clones (see Supplementary Information, Fig. S4c) . Thus, these results suggest that Bcl-X L enables mitochondria to cope with increased metabolic demand with high efficiency that preserves mitochondrial redox status, dependent upon the InsP 3 R.
Together the above results suggest that the effects of Bcl-X L at the ER are anti-apoptotic not only because they minimize the maximal delivery of Ca 2+ to mitochondria as previously thought, but also because Bcl-X L facilitates InsP 3 R-mediated Ca 2+ delivery to mitochondria that regulates mitochondrial bioenergetics. Such a model is consistent with a general scheme that links cellular resistance to apoptosis with the regulation of cellular metabolism 29, 30 . Furthermore, it is consistent with the observation that Bcl-X L does not stimulate an unregulated leak -which would be energetically costly -but rather modulates the activity of an exquisitely regulated permeability. Nevertheless, because our results do not establish a causal link between enhanced bioenergetics and apoptosis susceptibility, other models are also possible. For example, it may be that the ER Ca 2+ load per se, regulated by the interaction of Bcl-X L with the InsP 3 R, rather than Ca 2+ release, directly determines apoptotic susceptibility. Bcl-X L interacts with the InsP 3 R at the ER membranes and increases its sensitivity to very low levels of InsP 3 , resulting in increased Supplementary Information, Fig. S4 ).
channel gating and cytoplasmic [Ca 2+ ] i signals that enhance mitochondrial bioenergetics and increase apoptosis resistance. Anti-apoptotic Bcl-2 family members promote a more dynamic InsP 3 R response to achieve more sensitive coupling of Ca 2+ release to extracellular signals and to increase cell survival. We suggest that Bcl-X L interaction with the InsP 3 R Ca 2+ release channel is a critical cellular control point that couples the ER to apoptotic pathways. The interaction between Bcl-X L and InsP 3 R may provide a novel therapeutic target, with implications for processes involving apoptosis including cancer, neurodegeneration and cardiovascular disease.
METHODS
Cell culture and transfection. Spodoptera frugiperda (Sf9) cells were maintained in suspension culture at 27 °C in serum-free Sf-900 II SFM media (GIBCO/BLR, Gaithersburg, MD). A baculovirus expression system was used to transiently express Bcl-X L . COS-7 (Cercopithecus aethiops kidney) cells were grown in DMEM/high glucose medium containing 10% (v/v) fetal bovine serum (FBS) (GIBCO/BLR) in a humidified 95/5% air/CO 2 atmosphere. DT40 cells were maintained in suspension culture at 37 °C (95/5% air/CO 2 ) in RPMI 1640 media (GIBCO/BLR) supplemented with 10% (v/v) FBS, 1% chicken serum, 2 mM glutamine, 100 U ml −1 penicillin and 100 µg ml −1 streptomycin. Full-length human Bcl-X L cDNA was cloned into pIRES2-DsRed2 vector (Clontech, Palo Alto, CA). Cells were transfected with either empty vector pIRES2-DsRed2 or pBcl-X L -IRES2-DsRed2 using a Nucleofector Device (Amaxa, Gaithersburg, MD). For selection of stable clones, transfected cells were cultured for 2 weeks in the presence of 2 mg ml −1 G418. Transfected cells were identified on the basis of DsRed fluorescence and were further sub-cloned using fluorescence-activated cell sorting (Becton Dickinson, San Jose, CA) into individual wells of a 96-well plate. Bcl-X L expression was confirmed by western blot and quantified using infrared imaging Odyssey (LI-COR).
Biochemistry. Human Bcl-X L or Bcl-2 cDNA in pGEX6P-1 (Amersham Pharmacia, Piscataway, NJ) were expressed as GST-fusion proteins in Escherichia coli (BL-21; Stratagene, La Jolla, CA) and immobilized on glutathione-Sepharose 4B (Amersham Pharmacia). InsP 3 R (type 1) fragments were cloned into pcDNA3.1 or pcDNA3.1/V5 vectors (Invitrogen, Carlsbad, CA). COS-7 cells were transfected (Lipofectamine 2000), and 48-60 h later washed twice with PBS and harvested into 1 ml PBS containing 2% glycerol, 0.05% Triton and protease inhibitor cocktail (Sigma, St Louis, MO). After brief sonication (10 s) and centrifugation, total protein concentration in the lysate was adjusted to 5 mg ml −1 and incubated with GST-fusion protein (1 h, 4 °C). Beads were centrifuged, washed three times and prepared for western blot. Co-immunoprecipitation and western blot analysis were performed according to standard protocols. Baculoviral generation and protein purification. Baculoviruses were generated by first sub-cloning full-length human Bcl-X L into pVL1393 vector (BD PharMingen, Bedford, MA) with specific tags. pVL1393-flag-Bcl-X L and pVL1393-his-Bcl-X L were transfected into Sf9 cells and viral supernatants collected. Viral supernatants were used to infect Sf9 cells until recombinant Bcl-X L expression was maximized. Flag-tagged Bcl-X L was purified by antiFlagM2-agarose affinity beads (Sigma) and eluted by incubation with buffer 0.1 µg ml −1 Flag peptide. Bcl-X L cDNA for His-tagged recombinant Bcl-X L was cloned into pET-16b (Novagen, Madison, WI) and expressed in BL-21, and the resulting His-tagged Bcl-X L was purified on a Ni-NTA column (Qiagen, Valencia, CA). The plasmid pGEX-4T-1-tBid-his (gift from D. Newmeyer) was transformed into BL-21 and the cell lysate applied to glutathione-Sepharose, digested with thrombin (Novagen; 4 U ml −1 , 25 °C, 5 h ) and purified using Ni-NTA chromatography. PTYB1-mBax was obtained by inserting mouse Bax cDNA into pTYB1 vector (New England Biolabs, Beverly, MA). E. coli ER2566 (New England Biolabs) bearing the plasmid pTYB1-mBax were cultured and the fusion protein of Bax-chitin-binding protein was purified using a chitin-affinity column (New England Biolabs). Full-length Bax protein was eluted by incubating with 50 mM DTT at 16 °C for 40 h. All purified recombinant proteins were dialysed in buffer with 20 mM HEPES pH 7.5 and 20% glycerol, and stored at -80 °C. Protein samples for patch-clamping were first dialysed against buffer containing 10 mM HEPES pH 7.3, 140 mM KCl and 10% glycerol, and concentrated using Microcon (Millipore, Bedford, MA) to concentrations higher than 50 µM.
Electrophysiology. Sf9 cells were washed twice with PBS and suspended in a nuclear isolation solution containing: 150 mM KCl, 250 mM sucrose, 1.5 mM β-mercapoethanol, 10 mM Tris-HCl, 0.05 mM phenylmethylsulphonyl fluoride, protease inhibitor cocktail (Complete, Roche Diagnostics, Indianapolis, IN), pH 7.5. Nuclei were isolated using a Dounce glass homogenizer and plated onto a 1-ml glass-bottomed dish containing standard bath solution: 140 mM KCl, 10 mM HEPES and 0.5 mM BAPTA (free [Ca 2+ ] = 300 nM), pH 7.1. The pipette solution contained 140 mM KCl, 0.5 mM ATP, 10 mM HEPES, pH 7.1. The free [Ca 2+ ] in all solutions was adjusted to the desired level by the addition of an appropriate Ca 2+ chelator, as described previously 17 . Experiments were performed at room temperature. Data were acquired using an Axopatch-1D amplifier (Axon Instruments, Union City, CA) and single-channel analysis performed using QuB software (University of Buffalo).
Calcium measurement and apoptosis assay. DT40 cells were plated onto a glass-bottomed perfusion chamber mounted on the stage of an inverted microscope (Nikon Eclipse TE2000) and incubated with Fura-2 AM (Molecular Probes, Eugene, OR; 2 µM) for 30 min at room temperature in normal culture media. Cells were then continuously perfused with Hanks' balanced salt solution (Sigma), containing 1.8 mM CaCl 2 and 0.8 mM MgCl 2 , pH 7.4. In experiments in which calcium oscillations were measured, cells were perfused with complete culture media without phenol. Fura-2 was alternately excited at 340 and 380 nm, and the emitted fluorescence filtered at 510 nm was collected and recorded using a CCD-based imaging system running Ultraview software (Perkin-Elmer, Norwalk, CT). Thapsigargin (Sigma) was applied in Ca 2+ -free Hanks' solution containing 0.5 mM LaCl 3 to block Ca 2+ extrusion across the plasma membrane 31 . Dye calibration was achieved by applying experimentally determined constants to the standard equation: [Ca 2+ ] = K d β(R−R min )/(R max −R). Cell viability was determined after application of anti-BCR antibody (IgM; SouthernBiotech, Birmingham, AL) using DAPI staining (1 µg ml −1 ) and assays were performed on an LSR flow cytometer (Beckton Dickinson).
NAD(P)H measurements. DT40 cells (10 × 10
6 cells per ml) were suspended in Hanks' balanced salt solution (Sigma). Autofluorescence of NAD(P)H was monitored at 350/460 nm (excitation/emission) using a multi-wavelength excitation, dual-wavelength emission fluorimeter (Delta RAM, PTI , Birmingham, NJ). Experiments were performed at 37 °C.
Analysis and statistics. Data were summarized as the mean ± s.e.m. and the statistical significance of differences between means was assessed using unpaired t-tests or analysis of variance (ANOVA) for repeated measures, using Fisher's protected least-significant difference (PLSD) test. Differences between means were accepted as statistically significant at the 95% level (P < 0.05). 
